124 related articles for article (PubMed ID: 27941771)
1. Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation.
Fuji S; Löffler J; Savani BN; Einsele H; Kapp M
Bone Marrow Transplant; 2017 May; 52(5):657-662. PubMed ID: 27941771
[TBL] [Abstract][Full Text] [Related]
2. How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.
Fuji S; Rovó A; Ohashi K; Griffith M; Einsele H; Kapp M; Mohty M; Majhail NS; Engelhardt BG; Tichelli A; Savani BN
Bone Marrow Transplant; 2016 Aug; 51(8):1041-9. PubMed ID: 27042848
[TBL] [Abstract][Full Text] [Related]
3. Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.
Dadwal SS; Tegtmeier B; Liu X; Frankel P; Ito J; Forman SJ; Pullarkat V
Eur J Haematol; 2015 Mar; 94(3):235-42. PubMed ID: 25082161
[TBL] [Abstract][Full Text] [Related]
4. Glycemic variability is associated with poor outcomes in pediatric hematopoietic stem cell transplant patients.
Sopfe J; Campbell K; Keating AK; Pyle L; Liu AK; Verneris MR; Giller RH; Forlenza GP
Pediatr Blood Cancer; 2020 Nov; 67(11):e28626. PubMed ID: 33480469
[TBL] [Abstract][Full Text] [Related]
5. Respiratory Fungal Infections in Solid Organ and Hematopoietic Stem Cell Transplantation.
De La Cruz O; Silveira FP
Clin Chest Med; 2017 Dec; 38(4):727-739. PubMed ID: 29128021
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
Fabiani S; Fortunato S; Petrini M; Bruschi F
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation.
Fuji S; Kim SW; Mori S; Fukuda T; Kamiya S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Honda O; Kuwahara S; Tanosaki R; Heike Y; Tobinai K; Takaue Y
Transplantation; 2007 Oct; 84(7):814-20. PubMed ID: 17984832
[TBL] [Abstract][Full Text] [Related]
8. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation.
Sahin U; Toprak SK; Atilla PA; Atilla E; Demirer T
J Infect Chemother; 2016 Aug; 22(8):505-14. PubMed ID: 27344206
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.
Miceli MH; Churay T; Braun T; Kauffman CA; Couriel DR
Mycopathologia; 2017 Jun; 182(5-6):495-504. PubMed ID: 28124219
[TBL] [Abstract][Full Text] [Related]
11. The incidence and impact of dextrose dose on hyperglycemia from parenteral nutrition (PN) exposure in hematopoietic stem cell transplant (HSCT) recipients.
Sheean P; Braunschweig C
JPEN J Parenter Enteral Nutr; 2006; 30(4):345-50. PubMed ID: 16804133
[TBL] [Abstract][Full Text] [Related]
12. Early hyperglycemia after allogenic kidney transplantation.
Wyzgal J; Paczek L; Ziolkowski J; Pawlowska M; Rowiński W; Durlik M
Ann Transplant; 2007; 12(1):40-5. PubMed ID: 17953142
[TBL] [Abstract][Full Text] [Related]
13. Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients.
Tamura K; Drew R
Drugs Today (Barc); 2008 Jul; 44(7):515-30. PubMed ID: 18806902
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for invasive mold infections following allogeneic hematopoietic stem cell transplantation: a single center study of 190 recipients.
Li L; Wang J; Zhang W; Yang J; Chen L; Lv S
Scand J Infect Dis; 2012 Feb; 44(2):100-7. PubMed ID: 22066677
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
[TBL] [Abstract][Full Text] [Related]
16. Fusarium infection in hematopoietic stem cell transplant recipients.
Nucci M; Marr KA; Queiroz-Telles F; Martins CA; Trabasso P; Costa S; Voltarelli JC; Colombo AL; Imhof A; Pasquini R; Maiolino A; Souza CA; Anaissie E
Clin Infect Dis; 2004 May; 38(9):1237-42. PubMed ID: 15127334
[TBL] [Abstract][Full Text] [Related]
17. Time trends in fungal infections as a cause of death in hematopoietic stem cell transplant recipients: an autopsy study.
Alsharif M; Cameron SE; Young JA; Savik K; Henriksen JC; Gulbahce HE; Pambuccian SE
Am J Clin Pathol; 2009 Nov; 132(5):746-55. PubMed ID: 19846817
[TBL] [Abstract][Full Text] [Related]
18. Fungal infections in hematopoietic stem cell transplantation and solid-organ transplantation--focus on aspergillosis.
Nucci M; Anaissie E
Clin Chest Med; 2009 Jun; 30(2):295-306, vii. PubMed ID: 19375636
[TBL] [Abstract][Full Text] [Related]
19. Fungal colonization of the respiratory tract in allogeneic and autologous hematopoietic stem cell transplant recipients: a study of 573 transplanted patients.
Markowski J; Helbig G; Widziszowska A; Likus W; Kyrcz-Krzemień S; Jarosz U; Dziubdziela W; Markiewicz M
Med Sci Monit; 2015 Apr; 21():1173-80. PubMed ID: 25907308
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus after allogeneic hematopoietic stem cell transplantation.
Wędrychowicz A; Ciechanowska M; Stelmach M; Starzyk J
Horm Res Paediatr; 2013; 79(1):44-50. PubMed ID: 23296512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
